ACE2 and COVID-19: To further explore COVID-19 susceptibility in different types of cancer patients, the expression level of infection core genes (angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2)) were evaluated in normal and tumor samples [44, 45].